FindTrial
Sign In

The characteristics of peripheral blood lymphocyte subsets in preterm bronchopulmonary dysplasia

The characteristics of peripheral blood lymphocyte subsets in preterm bronchopulmonary dysplasia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052519
Enrollment
Unknown
Registered
2021-10-30
Start date
2021-11-08
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchopulmonary dysplasia

Interventions

full term control group:Nil
BPD group:Nil
preterm control group:Nil
oxygen therapy without BPD group:Nil

Sponsors

BaYi Children’s Hospital, the Seventh Medical Center of PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The BPD group was defined according to the diagnostic criteria of bronchopulmonary dysplasia, mainly referring to the premature infants who could not deoxygenate at 28 days after birth or 36 weeks of corrected gestational age.

Exclusion criteria

Exclusion criteria: 1. Congenital malformation, hematological malignancy and septicemia.

Design outcomes

Primary

MeasureTime frame
lymphocyte subset;—

Countries

China

Contacts

Public ContactHuang Jieting

BaYi Children’s Hospital, the Seventh Medical Center of PLA General Hospital

cdefab@163.com+86 15901306582

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026